⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20665191 | 0.86 | — | — | |
| SCHEMBL30352588 | 0.82 | — | — | |
| SCHEMBL22017410 | 0.82 | GRM2 (0.33) | — | |
| SCHEMBL22037815 | 0.82 | GRM2 (0.33) | — | |
| SCHEMBL24875930 | 0.82 | GRM2 (0.33) | — | |
| SCHEMBL28330953 | 0.79 | — | — | |
| SCHEMBL12498394 | 0.79 | — | — | |
| SCHEMBL7354461 | 0.77 | SLC6A1 (0.33) | — | |
| SCHEMBL3424277 | 0.73 | SIGMAR1 (0.47) | — | |
| SCHEMBL12310244 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10933054-B2 | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease | SHY Therapeutics LLC (US) | 2021-03-02 | — | — | US | disclosed |
| US-20200054614-A1 | COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE | SHY THERAPEUTICS, INC. | 2020-02-20 | — | — | US | disclosed |